AKZOINDIA2023-04-012023-06-30 AKZOINDIA2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member AKZOINDIA2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member AKZOINDIA2023-06-30 AKZOINDIA2023-04-012023-06-30in-bse-fin:OneReportableSegmentRevenue01Member AKZOINDIA2023-04-012023-06-30in-bse-fin:OneReportableSegmentResults01Member AKZOINDIA2023-04-012023-06-30in-bse-fin:OneReportableSegmentAssets01Member AKZOINDIA2023-04-012023-06-30in-bse-fin:OneReportableSegmentLiabilities01Member AKZOINDIA2023-06-30in-bse-fin:OneReportableSegmentLiabilities01Member AKZOINDIA2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500710 AKZOINDIA NOTLISTED Akzo Nobel India Limited Equity 2023-04-01 2024-03-31 2023-08-03 2023-07-14 INR Millions First quarter 10:45:00 12:10:00 2023-08-03 2023-08-03 Not applicable Geographical 2023-04-01 2023-06-30 Unaudited Consolidated 9991685000.00 81585000.00 10073270000.00 5159804000.00 473346000.00 59871000.00 832313000.00 34121000.00 193140000.00 1845103000.00 8597698000.00 1475572000.00 0.00 1475572000.00 401342000.00 -24347000.00 376995000.00 0.00 1098577000.00 0.00 0.00 0.00 0.00 1098577000.00 -5712000.00 1092865000.00 0.00 0.00 455400000.00 10 24.12 24.12 0.00 0.00 24.12 24.12 1. The Statement of Consolidated Unaudited Financial Results has been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on 03 August 2023. The figures for the quarter ended 30 June 2023 have been subjected to limited review by the statutory auditors. 2. The figures for the quarter ended 31 March 2023 have not been subjected to review/audit by the statutory auditors. These are balancing figures between Consolidated Audited Financial Statements for the financial year ended 31 March 2023 and year to date Consolidated Unaudited Financial Results for the nine months period ended 31 December 2022. 3. The Consolidated Unaudited Financial Results include the results of the following entities namely, Akzo Nobel India Limited (Parent) and ICI India Research and Technology Centre (Subsidiary), hereinafter referred to as the Group. 4. The Group operates in single segment viz. Coatings. Therefore, separate segment disclosures under the provisions of Ind AS 108 have not been given in respect of Consolidated Unaudited Financial Results for the quarter ended 30 June 2023. Adjustments due to rounding off -700000.00 Other Expenses 1845803000.00 Coatings 9991685000.00 9991685000.00 9991685000.00 Coatings 1509693000.00 1509693000.00 34121000.00 1475572000.00 Coatings 27391676000.00 27391676000.00 Coatings 27391676000.00 27391676000.00 Loss of defined benefit planms -7599000.00 -7599000.00 -1887000.00